Multi-institutional retrospective analysis of ultrahypofractionated radiotherapy for Japanese prostate cancer patients
Autor: | Katsumasa Nakamura, Motoi Watanabe, Eiichi Mizuno, Masashi Taka, Hiroaki Kobayashi, Takahisa Eriguchi, Hisato Nagano, Hideyasu Tsumura, Hajime Imada, Hiromichi Ishiyama, Koji Inaba |
---|---|
Rok vydání: | 2021 |
Předmět: |
Biochemical recurrence
Male medicine.medical_specialty Science medicine.medical_treatment Urogenital System Urological cancer Adenocarcinoma Radiosurgery Effective dose (radiation) Gastroenterology Article 030218 nuclear medicine & medical imaging Androgen deprivation therapy 03 medical and health sciences Prostate cancer 0302 clinical medicine Japan Internal medicine Medicine Humans Risk factor Radiation Injuries Aged Retrospective Studies Cancer Aged 80 and over Multidisciplinary business.industry Genitourinary system Prostatic Neoplasms Androgen Antagonists Middle Aged Prostate-Specific Antigen medicine.disease Combined Modality Therapy Neoadjuvant Therapy Progression-Free Survival Radiation therapy 030220 oncology & carcinogenesis Radiation Dose Hypofractionation business Follow-Up Studies |
Zdroj: | Scientific Reports Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021) |
ISSN: | 2045-2322 |
Popis: | To report outcomes and risk factors of ultrahypofractionated (UHF) radiotherapy for Japanese prostate cancer patients. This multi-institutional retrospective analysis comprised 259 patients with localized prostate cancer from 6 hospitals. A total dose of 35–36 Gy in 4–5 fractions was prescribed for sequential or alternate-day administration. Biochemical failure was defined according to the Phoenix ASTRO consensus. Toxicities were assessed using National Cancer Institute Common Toxicity Criteria version 4. Tumor control and toxicity rates were analyzed by competing risk frames. Median follow-up duration was 32 months (range 22–97 months). 2- and 3-year biochemical control rates were 97.7% and 96.4%, respectively. Initial prostate-specific antigen (p |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |